OMS Opto Chemicals

Neutralizer
Material Safety Data Sheet

04/13/2008

oms_image.GIF (3520 bytes)

Google
SECTION 1: MANUFACTURER INFORMATION
TDG classification not regulated
UN number n/a
Packaging group n/a
Product name OMS #1
Chemical formula proprietary
Chemical family solvent blend
Material use solvent/ refer to technical literature
Emergency telephone 514-426-3055,   TOLL FREE: 800-461-6637, BUSINESS HOURS.
WHMIS classification b3. d2a. d2b
SECTION 2: HARZARDEOUS INGREDIENTS
Product % t.l.v. c.a.s.# lc50 route species lc50 route, species
Diethylene glycol monoethylether 60-100 --- 111-90-0 5500 mg/kg (orl-rat)

8500 mg/kg (orl-rbt)

not available
Ethylene glycol 30-60 50ppm 107-21-1 4700 mg/kg (orl-rat)

9530 mg/kg (drm-rbt)

10..9 mg/kg (rat)
SECTION 3: PHYSICAL DATA
Boiling point 197 - 202 C
Physical state liquid
Odour solvent odor
Vapour pressure (mmhg) 0.08
Vapour density air=1 3.9
Freezing point n/a
Evaporation rate 0.01
pH n/a
Solubility in water 100%
Specific gravity.(water 1) 1.028
Flammability  
Flash point c, method  
Auto ignition temp.  
SECTION 4: FIRE AND EXPLOSION DATA
Flammability see flashpoint
Extinguishing media carbon dioxide, dry chemical, foam
Flashpoint 83. (t.c.c.)
Autoignition temp. not available
Upper flammable limit % 23.5
Lower flammable limit % 1.2
SECTION 5: REACTIVITY DATA
Chemical stability stable
Compatibility with other substances, yes  
no, which ones strong acids, strong bases, strong oxidizing agents, materials with hydroxyl compounds
Conditions to avoid excessive heat
Hazardeous polymerisation will not occur
Hazardeous decomposition products burning may produce carbon monoxide and/or carbon dioxide.
Stability stable
Comments  
SECTION 6: TOXICOLOGICAL PROPERTIES
INFORMATION: INFORMATION FOR THIS PRODUCT IS BASED AT 100% CONCENTRATION OF HARZARDEOUS INGREDIENTS
Skin contact Repeated contact with skin may cause dermatitis in sensitive individuals.
Skin absorption No evidence of adverse effects from available information.
Eye contact Causes irritation. causes pain. Causes eye burns. May cause conjunctivitis.
Inhalation May cause irritation of the nose and throat with headache, particularly from mists. High vapour concentrations (caused by heating material) in an enclosed and poorly ventilated workplace may produce nausea, vomiting, headache, dizziness, and irregular eye movements.
Swallowing, ingestion May cause abdominal discomfort or pain, nausea, vomiting, dizziness, drowsiness, malaise, blurring of vision, irritability, lumbar pain, oliguria, uremia, and central nervous systems effects, including irregular eye movement, convulsions and coma. cardiac failure and pulmonary oedema may develop, severe kidney damage follows the swallowing of large volumes of ethylene glycol. May be fatal. Few reports have been published describing the development of weakness of the facial muscles, diminished hearing and difficulty swallowing during stages of severe poisoning.
Effects of acute exposure Refer to route of entry
Effects of chronic exposure Repeated contact with skin may cause dermatitis in sensitive individuals. Ethylene glycol has been shown to produce dose-related teratogenic effects in rats and mice when given by gavage or in drinking water at high doses or concentrations. Also, in a preliminary study to assess the effects of exposure of pregnant rats and mice to aerosols at concentrations 150, 1000, and 2500 mg/m3 for 6 hours a day throughout the period of organogenesis, teratogenic effects were produced at the highest concentration, but only in mice. The conditions of these latter experiments did not allow a conclusion as to whether the developmental toxicity was mediated by inhalation of aerosol, percutaneous absorption of ethylene glycol from high aerosol concentrations by whole-body or nose-only exposure, it was shown that nose-only exposure resulted in maternal toxicity (1000 and 2500 mg/m3), and developmental toxicity with minimal evidence of teratogenicity (2500 mg/m3).

A further study in mice in mice no teratogenic effects could be produced when ethylene glycol was applied to the skin of pregnant mice over a period of organogenesis. The above observations suggest that ethylene glycol is to be regarded as an animal teratogen; there is currently no available information to suggest that ethylene glycol is to be regarded as an animal teatogen; there is currently no available information to suggest that ethylene glycol has caused birth defects in humans. Cutaneous application of ethylene glycol is ineffective in producing developmental toxicity; exposure to high aerosol is only minimally effective in producing developmental toxicity; the major route for producing developmental toxicity is perorally. Two chronic feeding studies, using rats and mice, have not produced any evidence that ethylene glycol causes dose related increases in tumor incidence, or a different pattern of tumors compared to untreated controls. The absence of a carcinogenic potential fro ethylene glycol has been supported by numerous in vitro genotoxicity studies showing that it does not produce mutagenic or clastogenic effects.

Irritancy of material see above
Carcinogenicity see above
Reproductive effects see above
Medical condition aggravated by overexposure kidney disease
SECTION 7: PREVENTATIVE MEASURES
Gloves/type Chemical resistant gloves, rubber
Clothing Apron or clothing to protect skin.
Respiratory type If respiratory irritation is experienced, use an approved air purifying respirator.
Eye/type Chemical safety goggles, face shield.
Ventilation Adequate ventilation to maintain 1 PPM.
Waste disposal In accordance with municipal, state or federal regulation.
SECTION 8: FIRST AID MEASURES
  skin: remove contaminated clothing and wash affected areas with plenty of soap and water. contact physician if irritation occurs.
  oral/ ingestion: seek immediate medical attention.
  inhalation: remove to fresh air, if irritation persist’s,get medical attention..

in case of ingestion:, have victim drink two glasses of water. never give anything by mouth if victim is unconscious. induce vomiting if conscious. get medical attention without delay.

Primary route of ingestion inhalation or ingestion. skin contact, eye contact
Notes to physician The principal toxic effects of ethylene glycol, when swallowed are kidney damage and metabolic acidosis. Ethanol is antidotal, and its early administration may block the formation of nephrotoxic metabolites of ethylene glycol in the liver. Ethanol should be give intravenously, as a 5% solution in sodium bicarbonate, at a rate of about 10ml ethanol per hour. A desired therapeutic level of ethanol in blood 100 mg/dl. hemodialysis may be required. 4-methylpirazole, a potent inhibitor of alcohol dehydrogenase, has been used therapeutically to decrease the metabolic consequences of ethylene glycol poisoning before coma, seizure and renal failure have occurred.

(20 mg/kg/day) pulmonary oedema with hypoxemia has been described in a number of patients following poisoning with ethylene glycol. The mechanism of production has not been elucidated, but it appears to be non cardiogenic in origin in several cases. Respiratory support with mechanical ventilation and positive end-expiratory pressure may be required. There may be cranial nerve involvement in the late stages of toxicity from swallowed ethylene glycol. In particular, effects have been reported involving the seventh, eighth and ninth cranial nerves, presenting with bilateral facial paralysis, diminished hearing, and dysphagia.

SECTION 8: ACCIDENTAL RELEASE MEASURES
  Disposal of collected product, residues and cleanup materials may be government regulated. Observe all applicable local, state/provincial, and federal waste management regulations. Mop up, or wipe up, or soak up with absorbent and contain for salvage or disposal. for large spills, provide diking or other appropriate techniques, such as several moppings or swabbings with appropriate solvents; washing with mild detergents or solutions or high pressure steam for large areas. Use typical industrial cleaning materials.

Local, state/provincial and federal requirements may apply to spills or releases of this material into the environment.

SECTION 9: PREPARATION OF INFORMATION
Emergency telephone 514-738-6637 OR TOLL FREE 800-461-6637, business hours
Prepared by: C.Ryser

REVISED 04/13/2008

Back to   OMS Optochemical Main Page

http://optochemicals.com

 

 

OMS, 177108 Canada Inc.
97 Columbus
Pointe Claire, Québec
Canada
H9R 4K3
Telephone Fax Toll Free
514-426-3055 514-426-1138 800-461-6637
Please add long distance and country code number where necessary.

 

E-mail us!
E-Mail Us!

e-mail address:  oms_optical@yahoo.com